These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 22095194)

  • 21. Prospective assessment of loss to follow-up: incidence and associated factors in a cohort of HIV-positive adults in rural Tanzania.
    Kalinjuma AV; Glass TR; Weisser M; Myeya SJ; Kasuga B; Kisung'a Y; Sikalengo G; Katende A; Battegay M; Vanobberghen F;
    J Int AIDS Soc; 2020 Mar; 23(3):e25460. PubMed ID: 32128998
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outcomes of patients lost to follow-up after antiretroviral therapy initiation in rural north-eastern South Africa.
    Ambia J; Kabudula C; Risher K; Xavier Gómez-Olivé F; Rice BD; Etoori D; Reniers G
    Trop Med Int Health; 2019 Jun; 24(6):747-756. PubMed ID: 30920699
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outcomes and associated risk factors of patients traced after being lost to follow-up from antiretroviral treatment in Lilongwe, Malawi.
    Weigel R; Hochgesang M; Brinkhof MW; Hosseinipour MC; Boxshall M; Mhango E; Nkwazi B; Tweya H; Kamlaka M; Chagwera F; Phiri S
    BMC Infect Dis; 2011 Jan; 11():31. PubMed ID: 21272350
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early mortality and loss to follow-up in HIV-infected children starting antiretroviral therapy in Southern Africa.
    Fenner L; Brinkhof MW; Keiser O; Weigel R; Cornell M; Moultrie H; Prozesky H; Technau K; Eley B; Vaz P; Pascoe M; Giddy J; Van Cutsem G; Wood R; Egger M; Davies MA;
    J Acquir Immune Defic Syndr; 2010 Aug; 54(5):524-32. PubMed ID: 20588185
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictors of loss to follow-up among children in the first and second years of antiretroviral treatment in Johannesburg, South Africa.
    Sengayi M; Dwane N; Marinda E; Sipambo N; Fairlie L; Moultrie H
    Glob Health Action; 2013 Jan; 6():19248. PubMed ID: 23364098
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Loss to follow-up among youth accessing outpatient HIV care and treatment services in Kisumu, Kenya.
    Ojwang' VO; Penner J; Blat C; Agot K; Bukusi EA; Cohen CR
    AIDS Care; 2016; 28(4):500-7. PubMed ID: 26565428
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Loss to follow-up correction increased mortality estimates in HIV-positive people on antiretroviral therapy in Mozambique.
    Anderegg N; Hector J; Jefferys LF; Burgos-Soto J; Hobbins MA; Ehmer J; Meier L; Maathuis MH; Egger M
    J Clin Epidemiol; 2020 Dec; 128():83-92. PubMed ID: 32828836
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High rates of loss to follow-up during the first year of pre-antiretroviral therapy for HIV patients at sites providing pre-ART care in Nigeria, 2004-2012.
    Agolory SG; Auld AF; Odafe S; Shiraishi RW; Dokubo EK; Swaminathan M; Dalhatu I; Onotu D; Abiri O; Debem H; Bashorun A; Ellerbrock TV
    PLoS One; 2017; 12(9):e0183823. PubMed ID: 28863160
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Competing risk of mortality on loss to follow-up outcome among patients with HIV on ART: a retrospective cohort study from the Zimbabwe national ART programme.
    Matsena Zingoni Z; Chirwa T; Todd J; Musenge E
    BMJ Open; 2020 Oct; 10(10):e036136. PubMed ID: 33028546
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incidence and risk factors of loss to follow-up among HIV-infected children in an antiretroviral treatment program.
    Kawilapat S; Salvadori N; Ngo-Giang-Huong N; Decker L; Kanjanavanit S; Puangsombat A; Preedisripipat K; Lertpienthum N; Akarathum N; Mekmullica J; Srirompotong U; Lallemant M; Le Coeur S; Traisathit P; Leroi C; Jourdain G
    PLoS One; 2019; 14(9):e0222082. PubMed ID: 31527875
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Loss to Follow-up Trends in HIV-Positive Patients Receiving Antiretroviral Treatment in Asia From 2003 to 2013.
    De La Mata NL; Ly PS; Nguyen KV; Merati TP; Pham TT; Lee MP; Choi JY; Ross J; Law MG; Ng OT
    J Acquir Immune Defic Syndr; 2017 Apr; 74(5):555-562. PubMed ID: 28129256
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Determinants of time to antiretroviral treatment initiation and subsequent mortality on treatment in a cohort in rural northern Malawi.
    Brown JP; Ngwira B; Tafatatha T; Crampin AC; French N; Koole O
    AIDS Res Ther; 2016; 13():24. PubMed ID: 27398087
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Estimating loss to follow-up in HIV-infected patients on antiretroviral therapy: the effect of the competing risk of death in Zambia and Switzerland.
    Schöni-Affolter F; Keiser O; Mwango A; Stringer J; Ledergerber B; Mulenga L; Bucher HC; Westfall AO; Calmy A; Boulle A; Chintu N; Egger M; Chi BH; ;
    PLoS One; 2011; 6(12):e27919. PubMed ID: 22205933
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improvement in mortality and retention among adult HIV-infected patients in the first 12 months of antiretroviral therapy in Dodoma urban district, Tanzania.
    Tweve EN; Kayabu D; Nassari NO; Todd J
    Trop Med Int Health; 2015 Jun; 20(6):791-6. PubMed ID: 25706518
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Loss to follow-up among children and adolescents growing up with HIV infection: age really matters.
    Kranzer K; Bradley J; Musaazi J; Nyathi M; Gunguwo H; Ndebele W; Dixon M; Ndhlovu M; Rehman A; Khan P; Vogt F; Apollo T; Ferrand RA
    J Int AIDS Soc; 2017 Jul; 20(1):21737. PubMed ID: 28715158
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term retention on antiretroviral therapy among infants, children, adolescents and adults in Malawi: A cohort study.
    Mugglin C; Haas AD; van Oosterhout JJ; Msukwa M; Tenthani L; Estill J; Egger M; Keiser O
    PLoS One; 2019; 14(11):e0224837. PubMed ID: 31725750
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improved retention of patients starting antiretroviral treatment in Karonga District, northern Malawi, 2005-2012.
    Koole O; Houben RM; Mzembe T; Van Boeckel TP; Kayange M; Jahn A; Chimbwandira F; Glynn JR; Crampin AC
    J Acquir Immune Defic Syndr; 2014 Sep; 67(1):e27-e33. PubMed ID: 24977375
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Survival probability and factors associated with time to loss to follow-up and mortality among patients on antiretroviral treatment in central Kenya.
    Wekesa P; McLigeyo A; Owuor K; Mwangi J; Ngugi E
    BMC Infect Dis; 2022 Jun; 22(1):522. PubMed ID: 35668350
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improved long-term antiretroviral treatment outcomes amongst patients receiving community-based adherence support in South Africa.
    Fatti G; Mothibi E; Shaikh N; Grimwood A
    AIDS Care; 2016 Nov; 28(11):1365-72. PubMed ID: 27251459
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A retrospective notes-based review of patients lost to follow-up from anti-retroviral therapy at Mulanje Mission Hospital, Malawi.
    Webb S; Hartland J
    Malawi Med J; 2018 Jun; 30(2):73-78. PubMed ID: 30627332
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.